|
|
|
|
| LEADER |
00949nam a2200253 i 4500 |
| 001 |
c000307697 |
| 003 |
CARM |
| 005 |
00000000000000.0 |
| 008 |
840316s1974 miu 0 eng d |
| 019 |
1 |
|
|a 10221951
|5 LACONCORD2021
|
| 035 |
|
|
|a (OCoLC)221657229
|5 LACONCORD2021
|
| 082 |
0 |
4 |
|a 615.58
|
| 100 |
1 |
|
|a Chodos, D. J.
|
| 245 |
1 |
0 |
|a Basics of bioavailability, and description of Upjohn single-dose study design /
|c [By] D.J. Chodos [and] A.R. Di Santo.
|
| 260 |
|
|
|a Kalamazoo, Mich. :
|b Upjohn Company,
|c 1974.
|
| 300 |
|
|
|a 32 p. :
|b ill.
|
| 500 |
|
|
|a Bibliography: p. 24-32.
|
| 650 |
|
0 |
|a Chemotherapy.
|
| 650 |
|
0 |
|a Chemotherapy, Combination.
|
| 650 |
|
0 |
|a Biopharmaceutics.
|
| 700 |
1 |
|
|a Di Santo, A. R.
|
| 852 |
8 |
|
|b CARM
|h A3:AR05C0
|i F04142
|p 0501996
|f BK
|
| 999 |
f |
f |
|i 08cc076c-2de0-588e-ba96-3e658796955a
|s 3527508b-c0f0-5daa-8736-9c5834ebae78
|
| 952 |
f |
f |
|p Can circulate
|a CAVAL
|b CAVAL
|c CAVAL
|d CARM 1 Store
|e F04142
|f A3:AR05C0
|h Other scheme
|i book
|m 0501996
|